Discover how generative AI is transforming the drug discovery process. NVIDIA's Clara framework and BioNemo service offer state-of-the-art AI models for imaging, molecule design, and protein prediction. Explore the key stages of drug discovery and the potential of generative models in virtual screening and optimizing drug candidates. Accelerate your research and save valuable time with NVIDIA's DGX Cloud infrastructure. #DrugDiscovery #GenerativeAI #NVIDIAClara #BioNemo #AIModels #VirtualScreening #DrugOptimization #DGXCloud #ResearchAdvancements #HealthcareTechnology

свернуть